Table 4.
Comparison of the CHF patient groups on the days 0, 7 and 15 during the treatments. Column Variable gives the names of the five measurements. For each of the four datasets, sA, tA, sB and tB, the second column (sN and tN) gives the averaged value and the standard deviation of the study and test Normal datasets. The 3th and 4th columns give the measurements of the CHF patients on day 0 of the treatment and their P-values compared with the Normal datasets. The 5th, 6th, 7th and 8th columns are defined in a similar way.
| Variable | sN | sA0 | sA0 vs sN | sA7 | sA7 vs sN | sA15 | sA15 vs sN |
| Ang_II (pg/ml) | 31.57±5.38 | 94.83±6.13 | 7.31E-61 | 93.40±6.12 | 2.82E-60 | 70.62±5.59 | 1.65E-50 |
| hs_CRP (mg/l) | 2.30±0.56 | 8.11±1.04 | 2.04E-36 | 7.91±1.03 | 6.87E-36 | 5.77±0.94 | 2.52E-28 |
| LVESVI | 30.65±4.00 | 54.27±4.09 | 1.66E-44 | 53.25±3.81 | 4.24E-46 | 47.08±3.80 | 6.70E-36 |
| LVEF | 59.68±2.43 | 36.85±2.78 | 8.00E-54 | 37.62±2.68 | 1.06E-54 | 41.62±2.38 | 3.95E-54 |
| NT_proBNP (pg/l) | 103.90±9.27 | 4318.57±298.86 | 9.77E-47 | 4103.65±419.12 | 3.79E-40 | 3111.80±409.03 | 8.60E-36 |
| Variable | tN | tA0 | tA0 vs tN | tA7 | tA7 vs tN | tA15 | tA15 vs tN |
| Ang_II (pg/ml) | 32.29±4.38 | 93.10±5.75 | 4.68E-29 | 92.00±5.80 | 1.47E-28 | 71.10±8.37 | 1.52E-16 |
| hs_CRP (mg/l) | 1.70±0.33 | 8.00±1.07 | 2.24E-17 | 7.82±1.06 | 3.17E-17 | 5.54±0.98 | 6.78E-14 |
| LVESVI | 31.74±3.53 | 54.75±4.05 | 1.06E-21 | 53.60±3.99 | 2.87E-21 | 47.40±3.97 | 9.68E-17 |
| LVEF | 58.77±4.02 | 33.50±2.04 | 2.36E-35 | 34.30±2.41 | 1.50E-33 | 38.60±2.82 | 2.29E-27 |
| NT_proBNP (pg/l) | 104.51±9.45 | 4300.05±287.04 | 7.51E-24 | 3211.80±295.34 | 3.77E-21 | 2149.60±259.82 | 8.78E-19 |
| Variable | sN | sB0 | sB0 vs sN | sB7 | sB7 vs sN | sB15 | sB15 vs sN |
| Ang_II (pg/ml) | 31.57±5.38 | 94.56±6.39 | 4.35E-60 | 93.34±6.48 | 1.01E-58 | 47.51±6.98 | 1.88E-19 |
| hs_CRP (mg/l) | 2.30±0.56 | 8.07±1.04 | 2.94E-37 | 7.66±1.04 | 1.06E-35 | 3.11±0.63 | 1.83E-09 |
| LVESVI | 30.65±4.00 | 53.95±3.85 | 8.12E-48 | 52.78±3.81 | 1.63E-46 | 40.56±3.27 | 2.69E-25 |
| LVEF | 59.68±2.43 | 36.90±3.09 | 6.26E-50 | 37.54±3.09 | 4.45E-49 | 46.37±2.46 | 1.01E-43 |
| NT_proBNP (pg/l) | 103.90±9.27 | 4321.17±301.67 | 9.64E-48 | 3935.17±401.83 | 4.02E-41 | 2065.41±371.46 | 4.70E-31 |
| Variable | tN | tB0 | tB0 vs tN | tB7 | tB7 vs tN | tB15 | tB15 vs tN |
| Ang_II (pg/ml) | 32.29±4.38 | 93.00±6.01 | 6.62E-28 | 91.90±5.97 | 8.16E-28 | 48.00±8.57 | 5.60E-08 |
| hs_CRP (mg/l) | 1.70±0.33 | 7.93±1.06 | 2.18E-17 | 7.77±1.00 | 9.12E-18 | 3.26±0.89 | 1.55E-07 |
| LVESVI | 31.74±3.53 | 54.75±3.65 | 6.06E-24 | 53.25±3.39 | 1.38E-24 | 40.85±3.77 | 1.14E-10 |
| LVEF | 58.77±4.02 | 33.55±2.14 | 3.95E-35 | 34.45±2.46 | 3.52E-33 | 42.55±2.87 | 7.61E-23 |
| NT_proBNP (pg/l) | 104.51±9.45 | 4300.10±286.65 | 7.31E-24 | 3210.80±294.84 | 3.68E-21 | 1390.60±238.24 | 9.79E-16 |